Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Redmile Group, Llc Insider Profile
11 Followers
Redmile Group, Llc, Ten Percent Owner at Array Biopharma, holds 3.08M shares in IGM Biosciences (Ticker: IGMS), holds 5.62M shares in Shattuck Labs (Ticker: STTK), holds 16.41M shares in Augmedix (Ticker: AUGX).
Redmile Group, Llc Array Biopharma (~ARRY)Ten Percent Owner
Array Biopharma (~ARRY)
Ten Percent Owner
Ranked #10,896 out of 97,948 Corporate Insiders
Profitable Transactions
16 out of 38 Profitable Transactions
Average Return
+6.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
A breakdown of Redmile Group, Llc's holdings
Insider Roles
Roles that Redmile Group, Llc holds in companies
Most Profitable Insider Trade
The most profitable trade made by Redmile Group, Llc
Redmile Group, Llc's Trading History
Array Biopharma
Sep 30, 2016
―
Informative Sell
15.85M
$916.36M
Amicus
Jun 13, 2016
Ten Percent Owner
Informative Buy
477.36K
$151.46M
Alder Biopharmaceuticals
Oct 24, 2019
―
Uninformative Sell
―
$0.00
Xeris Pharmaceuticals
Feb 21, 2019
Ten Percent Owner
Informative Buy
5.88M
$6.42M
Allakos
Jul 24, 2018
Ten Percent Owner
Uninformative Buy
―
$1.23M
Replimune Group
Jul 25, 2018
Ten Percent Owner
Uninformative Buy
―
$6.03M
Fate Therapeutics
Dec 28, 2023
Director, Ten Percent Owner
Uninformative Buy
6.16M
$93.32M
Gritstone Oncology
Oct 03, 2018
Ten Percent Owner
Uninformative Buy
―
$3.28M
Vapotherm
Nov 16, 2018
Ten Percent Owner
Uninformative Buy
―
$1.28M
TCR2 Therapeutics
Feb 21, 2019
―
Uninformative Buy
―
$1.19M
Hookipa Pharma
Apr 24, 2019
Ten Percent Owner
Uninformative Buy
―
$722.51K
IGM Biosciences
Apr 01, 2024
Director, Ten Percent Owner
Uninformative Buy
―
$29.09M
Cabaletta Bio
Oct 29, 2019
Ten Percent Owner
Uninformative Buy
―
$11.71M
Aprea Therapeutics
Feb 16, 2021
Ten Percent Owner
Informative Sell
2.79M
$11.23M
Atreca
Jun 24, 2019
Ten Percent Owner
Uninformative Buy
―
$57.22K
Akero Therapeutics
Jun 24, 2019
Ten Percent Owner
Uninformative Buy
―
$17.90M
Stoke Therapeutics
Jun 24, 2019
Ten Percent Owner
Uninformative Buy
―
$9.06M
Beam Therapeutics
Feb 11, 2020
Ten Percent Owner
Uninformative Buy
―
$37.93M
Neurogene
Apr 06, 2020
Ten Percent Owner
Informative Buy
2.01M
$189.05M
Pliant Therapeutics
Jun 09, 2020
Ten Percent Owner
Uninformative Buy
―
$28.30M
Repare Therapeutics
Jun 25, 2020
Ten Percent Owner
Uninformative Buy
―
$7.46M
Nurix Therapeutics
Jul 30, 2020
Ten Percent Owner
Uninformative Buy
―
$17.15M
Annexon Biosciences
Jul 30, 2020
Ten Percent Owner
Uninformative Buy
―
$10.58M
AlloVir
Aug 05, 2020
Ten Percent Owner
Uninformative Buy
―
$661.99K
Kymera Therapeutics
Aug 25, 2020
Ten Percent Owner
Uninformative Buy
―
$64.28M
Shattuck Labs
Apr 01, 2024
Director, Ten Percent Owner
Uninformative Sell
―
$49.92M
Verve Therapeutics
Jun 23, 2021
Ten Percent Owner
Uninformative Buy
―
$24.77M
AbSci
Mar 05, 2024
Director
Informative Buy
1000.00K
$46.30M
Invivyd
Aug 12, 2021
Ten Percent Owner
Uninformative Buy
―
$14.41M
Science 37
Mar 13, 2024
―
Uninformative Sell
5.85M
$0.00
Augmedix
Mar 19, 2024
Director, Ten Percent Owner
Uninformative Buy
―
$65.96M
Entrada Therapeutics Inc
Nov 04, 2021
Ten Percent Owner
Uninformative Buy
―
$26.89M
MedAvail Holdings
Jul 06, 2022
Director, Ten Percent Owner
Uninformative Buy
18.07M
$73.57M
Zymeworks
Oct 17, 2022
Ten Percent Owner
Uninformative Buy
153.32K
$60.03M
RayzeBio, Inc.
Sep 21, 2023
―
Uninformative Buy
―
$116.09M
ADC Therapeutics
―
Ten Percent Owner
―
―
List of latest transactions for each holding click on a transaction to see Redmile Group, Llc's performance on stock
You May Also Like
Redmile Group, Llc insider profile FAQ
What is the percentage of profitable transactions made by Redmile Group, Llc?
The percentage of profitable transactions made by Redmile Group, Llc is 42%.
What is the average return per transaction made by Redmile Group, Llc?
The average return per transaction made by Redmile Group, Llc is 6.80%.
What stocks does Redmile Group, Llc hold?
Redmile Group, Llc holds: ~ARRY, FOLD, ALDR, XERS, ALLK, REPL, FATE, GRTS, VAPO, TCRR, HOOK, IGMS, CABA, APRE, BCEL, AKRO, STOK, BEAM, NGNE, PLRX, RPTX, NRIX, ANNX, ALVR, KYMR, STTK, VERV, ABSI, IVVD, SNCE, AUGX, TRDA, MDVLQ, ZYME, RYZB, ADCT stocks.
What was Redmile Group, Llc’s latest transaction?
Redmile Group, Llc latest transaction was an Uninformative Buy of ―.
What was Redmile Group, Llc's most profitable transaction?
Redmile Group, Llc’s most profitable transaction was an Informative Buy of FATE stock on June 17, 2020. The return on the trade was 165.20%.
What is Redmile Group, Llc's role in Array Biopharma?
Redmile Group, Llc's role in Array Biopharma is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.